238 related articles for article (PubMed ID: 4208341)
21. [Clinical studies with a new antihypertensive agent, Bendigon].
Wardemann H
Med Welt; 1970 Sep; 37():1617-20. PubMed ID: 5526791
[No Abstract] [Full Text] [Related]
22. Lessons from ALLHAT. Are low budget diuretics first line therapy in hypertension?
Unger T
Z Kardiol; 2004 May; 93(5):349-56. PubMed ID: 15160270
[TBL] [Abstract][Full Text] [Related]
23. You should treat patients over the age of 80 who have hypertension.
Lundberg GD
Medscape J Med; 2008; 10(8):185. PubMed ID: 18924637
[No Abstract] [Full Text] [Related]
24. [Clinical testing of a new potassium-saving diuretic for the treatment of hypertension].
Vetter G
Munch Med Wochenschr; 1973 Dec; 115(49):2249-50. PubMed ID: 4592408
[No Abstract] [Full Text] [Related]
25. Demonstration of an additive antihypertensive effect of prazosin and polythiazide in out-patient.
Kuokkanen K; Mattila MJ
Curr Ther Res Clin Exp; 1975 May; 17(5):431-6. PubMed ID: 805026
[No Abstract] [Full Text] [Related]
26. Impact of ASCOT on hypertension treatment and guidelines in older adults.
Sheridan R; Baldwin N
Age Ageing; 2006 May; 35(3):214-7. PubMed ID: 16638764
[No Abstract] [Full Text] [Related]
27. [Prevention of hypokalemia in the diuretic treatment of hypertensives].
Laplante L
Union Med Can; 1985 Mar; 114(3):207-11. PubMed ID: 4002433
[No Abstract] [Full Text] [Related]
28. Benefits of low vs high dosages of diuretics.
Kaplan NM
Clin Ther; 1984; 6(2):198-204. PubMed ID: 6705013
[TBL] [Abstract][Full Text] [Related]
29. A comparative trial of fixed ratio beta-adrenoceptor blocker and diuretic combination products in moderate hypertension.
Watt SJ; Lee MR
Pharmatherapeutica; 1980; 2(7):487-93. PubMed ID: 6111083
[TBL] [Abstract][Full Text] [Related]
30. The role of low-dose diuretics in essential hypertension.
Knauf H
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S1-7. PubMed ID: 7508054
[TBL] [Abstract][Full Text] [Related]
31. Controversies in the treatment of hypertension.
Lowenthal DT; Broderman SJ
Compr Ther; 1984 Feb; 10(2):22-8. PubMed ID: 6368106
[No Abstract] [Full Text] [Related]
32. [Is a combined treatment of hypertension worthwhile?].
Jahnecke J
Med Welt; 1972 Sep; 23(36):1217-21. PubMed ID: 4562535
[No Abstract] [Full Text] [Related]
33. [Clinical evaluation of hygroton K (author's transl)].
Rylski M; Rawczyńska-Englert I; Hoffman M
Przegl Lek; 1981; 38(10):735-6. PubMed ID: 7036232
[No Abstract] [Full Text] [Related]
34. Update of diuretics in the treatment of hypertension.
Padilla MC; Armas-Hernández MJ; Hernández RH; Israili ZH; Valasco M
Am J Ther; 2007; 14(2):154-60. PubMed ID: 17414583
[TBL] [Abstract][Full Text] [Related]
35. [Experiences with a new antihypertensive agent].
Stampfer E
Wien Klin Wochenschr; 1971 Jan; 83(4):66-9. PubMed ID: 4994618
[No Abstract] [Full Text] [Related]
36. Clinical evaluation of metolazone, a long-acting antihypertensive/diuretic.
Weingarten C
Curr Ther Res Clin Exp; 1976 Dec; 20(6):737-44. PubMed ID: 827419
[No Abstract] [Full Text] [Related]
37. Therapeutic implications from clinical trials for the treatment of hypertension.
Kaplan NM
J Clin Hypertens; 1986 Sep; 2(3 Suppl):22S-27S. PubMed ID: 3540225
[No Abstract] [Full Text] [Related]
38. Metabolic side effects and cardiovascular events of diuretics: should a diuretic remain the first choice therapy in hypertension treatment? The case of yes.
Papadopoulos DP; Papademetriou V
Clin Exp Hypertens; 2007 Nov; 29(8):503-16. PubMed ID: 18058476
[TBL] [Abstract][Full Text] [Related]
39. A multicentre open trial indapamide in general practice.
Bowker CH; Murphy MA
Postgrad Med J; 1981; 57 Suppl 2():53-6. PubMed ID: 7033948
[TBL] [Abstract][Full Text] [Related]
40. [The clinical spectrum of potassium-sparing diuretics].
Greminger P; Suter PM
Praxis (Bern 1994); 1997 Apr; 86(14):556-60. PubMed ID: 9198849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
